ArticleInternational journal of nanomedicine2015

Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity.

Gregory Marslin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.